comparemela.com
2
3
4
5
6
7
8
Latest Breaking News On - Dee datta - Page 1 : comparemela.com
Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer
SOUTH SAN FRANCISCO, Calif., January 03, 2024 Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D., as Chief Technology Officer (CTO).
South-san-francisco
California
United-states
South-korea
Han
Dtx-pharma
Tressa-frankel
Dee-datta
Charles-allerson
National-institutes-of-health
Harvard-university
Linkedin
Lessons from a biotech downturn: Funding challenges, an IPO dry spell and what to expect in 2024
BioPharma
William-blair
Athira-pharma
Kevin-eisele
Novo-nordisk-ozempic
Eli-lilly-mounjaro
Dee-datta
Edward-kaye
Andrew-gengos
Nasdaq
Biopharma-dive-wednesday
Jordan-saxe
Switch-therapeutics
Switch Therapeutics launches with $52M to capitalize on RNA medicine 'era'
BioPharma
California
United-states
California-institute-of-technology
South-korea
South-san-francisco
Han
Dee-datta
Eli-lilly
Alnylam-pharmaceuticals
Arrowhead-pharmaceuticals
Dicerna-pharmaceuticals
Ionis-pharmaceuticals
Switch Therapeutics Raises $52M in Series A Funding
FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!
South-korea
Han
Dee-datta
Eli-lilly
Harvard-medical-school
Switch-therapeutics
South-san-francisco
Insight-partners
Upfront-ventures
Ono-venture-investment
Digitalis-ventures
Dolby-family-ventures
Switch Therapeutics Comes Out of Stealth to Advance First-of-its-Kind RNAi Technology
Switch Therapeutics announced $52M in early funding to develop conditionally activated small interfering (CASi) RNA therapeutics.
South-korea
Han
Wilson-hill
Alisa-scherer
Eli-lilly
Alicia-irurzun
Bill-goddard
Dee-datta
Saumya-das
John-rossi
Astrazeneca
Switch-therapeutics
vimarsana © 2020. All Rights Reserved.